猫用ワクチンの世界市場レポート 2025

猫用ワクチン市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.0％で17億8,000万米ドルに成長します。予測期間の成長は、ペット飼育の増加傾向、可処分所得の増加、獣医サービスの需要増加、政府や獣医団体の取り組み、人々の間で動物の健康に対する意識が高まっていることに起因しています。予測期間の主な動向としては、先進的な猫用ワクチンの開発、革新的でより効果的な製品、新規ワクチン技術、混合ワクチンの革新、個別化予防接種の開発などが挙げられます。

人獣共通感染症の増加が猫用ワクチン市場の成長を牽引すると予想されます。人獣共通感染症は、細菌、ウイルス、真菌、寄生虫などのさまざまな病原体を通じて動物からヒトに感染する感染症です。これらの病気は、直接的な接触、媒介動物、汚染された環境などを介して感染します。一般的な人獣共通感染症には、ライム病、狂犬病、トキソプラズマ症、サルモネラ症、ブルセラ病などがあります。人獣共通感染症の増加要因には、気候変動、抗生物質耐性、野生動物の取引などがあります。猫用ワクチンは、猫から人間への感染リスクを減らすことで、これらの病気の管理に役立っています。例えば、トキソプラズマ症や猫ひっかき病などの病気を予防します。猫にワクチンを接種することで、人獣共通感染症が人間の健康に与える影響を軽減し、公衆衛生を支え、ペットと飼い主の双方にとってより健康的な環境を作り出すことができます。英国政府が2024年2月に発表した報告書によると、イングランドでは2023年第4四半期に335件のライム病が確認され、2022年同期の273件から増加しました。この増加は、人獣共通感染症の増加による猫用ワクチンの需要拡大を裏付けています。

猫用ワクチン市場の主要企業は、免疫反応を高め、ワクチンの有効性を高めるために高度なリボ核酸（RNA）粒子技術を使用したNOBIVAC NXTワクチンなどの製品で技術革新を進めています。この技術では、ナノ粒子に包まれたRNA分子が細胞に遺伝的指示を与え、標的とする免疫反応を引き起こす特定のタンパク質の産生を促します。例えば、2024年6月、MSDアニマルヘルス社は、NOBIVAC NXT Feline-3 RabiesおよびNOBIVAC NXT Canine-3 Rabiesを含むNOBIVAC NXT Rabiesポートフォリオを発売しました。これらのワクチンは、アジュバントや防腐剤を使用せず、有効性を維持しながら安全性を向上させ、犬猫の狂犬病に対する強固な防御を提供します。これらのワクチンは、体液性免疫応答と細胞媒介免疫応答の両方を刺激し、狂犬病ウイルスに対する包括的な防御を実現します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界猫用ワクチンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の猫用ワクチン市場：成長率分析
• 世界の猫用ワクチン市場の実績：規模と成長, 2019-2024
• 世界の猫用ワクチン市場の予測：規模と成長, 2024-2029, 2034F
• 世界猫用ワクチン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の猫用ワクチン市場ワクチンの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 改変または弱毒化されたライブ
• 不活性化
• その他のワクチンの種類
• 世界の猫用ワクチン市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 猫白血病
• 猫汎白血球減少症
• 猫の呼吸器疾患
• 猫の狂犬病
• その他の病気
• 世界の猫用ワクチン市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 弱毒生ワクチン
• 結合ワクチン
• 不活化ワクチン
• サブユニットワクチン
• トキソイドワクチン
• デオキシリボ核酸（DNA）ワクチン
• 組み換えワクチン
• 世界の猫用ワクチン市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射剤
• 鼻腔内
• オーラル
• 世界の猫用ワクチン市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 獣医クリニック
• ペットショップ
• オンライン小売業者
• 世界の猫用ワクチン市場、改変または弱毒化された生菌の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 猫ウイルス性鼻気管炎（FVR）ワクチン
• 猫カリシウイルス（FCV）ワクチン
• 猫汎白血球減少症（FPV）ワクチン
• 世界の猫用ワクチン市場、不活性化のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 不活化猫白血病ウイルス（FeLV）ワクチン
• 不活化猫伝染性腹膜炎（FIP）ワクチン
• 世界の猫用ワクチン市場、その他のワクチンの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 組み換えワクチン
• DNAワクチン
• サブユニットワクチン
• 混合ワクチン

第7章 地域別・国別分析

• 世界の猫用ワクチン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の猫用ワクチン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 猫用ワクチン市場：競合情勢
• 猫用ワクチン市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • MSD Animal Health Overview, Products and Services, Strategy and Financial Analysis
  • Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Intas Pharmaceuticals Ltd.
• Ceva Sante Animale
• Virbac
• Neogen Corporation
• Indian Immunologicals Ltd.
• Jinyu Bio-technology Co. Ltd.
• Ourofino Animal Health SA
• Biogenesis Bago SA
• Valley Vet Supply
• HIPRA Corporation
• Bioveta AS
• China Animal Husbandry Group
• Veterinary Pharmaceutical Solutions
• Torigen Pharmaceuticals Inc.
• KM Vet Pharm Sdn Bhd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 猫用ワクチン市場2029：新たな機会を提供する国
• 猫用ワクチン市場2029：新たな機会を提供するセグメント
• 猫用ワクチン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A cat vaccine is a biological agent designed to safeguard cats from infectious diseases by activating their immune system to identify and combat specific pathogens. These vaccines use weakened or inactivated versions of viruses or bacteria responsible for diseases, which prompts the cat's immune system to generate antibodies without causing illness.

Ther main categories of cat vaccines are modified or attenuated live vaccines, inactivated vaccines, and others. Modified or attenuated live vaccines involve weakening the pathogen to prevent it from causing illness in cats. These vaccines address various diseases such as feline leukemia, feline panleukopenia, feline respiratory infections, and feline rabies. The available vaccine technologies include attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, and recombinant vaccines. They can be administered through different methods, including injections, intranasal, and oral routes. These vaccines are available through various channels, including veterinary clinics, pet stores, and online retailers.

The cat vaccine market research report is one of a series of new reports from The Business Research Company that provides cat vaccine market statistics, including cat vaccine industry global market size, regional shares, competitors with a cat vaccine market share, detailed cat vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the cat vaccine industry. This cat vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cat vaccine market size has grown strongly in recent years. It will grow from $1.15 billion in 2024 to $1.26 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rising emergence of new diseases in cats, increasing prevalence of animal diseases, increasing livestock population of animals, increasing population of companion animals, and increasing zoonotic diseases.

The cat vaccine market size is expected to see strong growth in the next few years. It will grow to $1.78 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to the rising trend of pet ownership, increasing disposable income, increasing demand for veterinary services, government and veterinary organization initiatives, and growing awareness of animal health among people. Major trends in the forecast period include development of advanced cat vaccines, innovative and more effective products, novel vaccine technologies, innovations in combination vaccines, and the development of personalized vaccinations.

The rise in zoonotic diseases is expected to drive the growth of the cat vaccine market. Zoonotic diseases are infections that can transfer from animals to humans through various pathogens such as bacteria, viruses, fungi, or parasites. These diseases can be transmitted via direct contact, vectors, or contaminated environments. Common zoonotic diseases include Lyme disease, rabies, toxoplasmosis, salmonellosis, and brucellosis. Factors contributing to the increase in zoonotic diseases include climate change, antibiotic resistance, and wildlife trade. Cat vaccines help manage these diseases by reducing the risk of transmission from cats to humans. For instance, they protect against diseases such as toxoplasmosis and cat scratch fever. By vaccinating cats, the impact of zoonotic diseases on human health is mitigated, supporting public health and creating a healthier environment for both pets and their owners. According to a February 2024 report from the Government of the United Kingdom, England saw 335 confirmed cases of Lyme disease in the fourth quarter of 2023, up from 273 cases in the same period in 2022. This increase underscores the growing demand for cat vaccines driven by rising zoonotic diseases.

Key players in the cat vaccine market are innovating with products such as NOBIVAC NXT vaccines, which use advanced Ribonucleic acid (RNA)-particle technology to boost immune responses and enhance vaccine effectiveness. This technology involves RNA molecules encased in nanoparticles that deliver genetic instructions to cells, prompting them to produce specific proteins that trigger a targeted immune response. For example, in June 2024, MSD Animal Health Inc. launched the NOBIVAC NXT Rabies portfolio, including NOBIVAC NXT Feline-3 Rabies and NOBIVAC NXT Canine-3 Rabies. These vaccines offer robust protection against rabies for cats and dogs without adjuvants or preservatives, improving safety while maintaining efficacy. They stimulate both humoral and cell-mediated immune responses for comprehensive protection against the rabies virus.

In September 2024, Boehringer Ingelheim Group, based in Germany, acquired Saiba Animal Health AG, a Switzerland-based company specializing in cat vaccines. This acquisition aligns with Boehringer Ingelheim's strategy to expand its portfolio and leverage Saiba's expertise in the field.

Major companies operating in the cat vaccine market are Merck & Co. Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., MSD Animal Health, Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Sante Animale, Virbac, Neogen Corporation, Indian Immunologicals Ltd., Jinyu Bio-technology Co. Ltd., Ourofino Animal Health SA, Biogenesis Bago SA, Valley Vet Supply , HIPRA Corporation, Bioveta AS, China Animal Husbandry Group, Veterinary Pharmaceutical Solutions, Torigen Pharmaceuticals Inc., KM Vet Pharm Sdn Bhd.

North America was the largest region in the cat vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cat vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cat vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cat vaccine market consists of sales of the bordetella vaccine, rabies vaccine, and feline immunodeficiency virus (FIV) vaccine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cat Vaccine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cat vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cat vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cat vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Vaccine Type: Modified Or Attenuated Live; Inactivated; Other Vaccine Types
• 2) By Disease Type: Feline Leukemia; Feline Panleukopenia; Feline Respiratory Diseases; Feline Rabies; Other Diseases
• 3) By Technology: Attenuated Live Vaccines; Conjugate Vaccines; Inactivated Vaccines; Subunit Vaccines; Toxoid Vaccines; Deoxyribonucleic Acid (DNA) Vaccines; Recombinant Vaccines
• 4) By Route Of Administration: Injectables; Intranasal; Oral
• 5) By Distribution Channel: Veterinary Clinics; Pet Stores; Online Retailers
• Subsegments:
• 1) By Modified or Attenuated Live: Feline Viral Rhinotracheitis (FVR) Vaccine; Feline Calicivirus (FCV) Vaccine; Feline Panleukopenia (FPV) Vaccine
• 2) By Inactivated: Inactivated Feline Leukemia Virus (FeLV) Vaccine; Inactivated Feline Infectious Peritonitis (FIP) Vaccine
• 3) By Other Vaccine Types: Recombinant Vaccines; DNA Vaccines; Subunit Vaccines; Combination Vaccines
• Companies Mentioned: Merck & Co. Inc.; Boehringer Ingelheim International GmbH; Zoetis Inc.; MSD Animal Health; Elanco Animal Health Incorporated
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cat Vaccine Market Characteristics

3. Cat Vaccine Market Trends And Strategies

4. Cat Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Cat Vaccine Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cat Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cat Vaccine Market Growth Rate Analysis
• 5.4. Global Cat Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cat Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cat Vaccine Total Addressable Market (TAM)

6. Cat Vaccine Market Segmentation

• 6.1. Global Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Modified Or Attenuated Live
• Inactivated
• Other Vaccine Types
• 6.2. Global Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Feline Leukemia
• Feline Panleukopenia
• Feline Respiratory Diseases
• Feline Rabies
• Other Diseases
• 6.3. Global Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Attenuated Live Vaccines
• Conjugate Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• Deoxyribonucleic Acid (DNA) Vaccines
• Recombinant Vaccines
• 6.4. Global Cat Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectables
• Intranasal
• Oral
• 6.5. Global Cat Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Veterinary Clinics
• Pet Stores
• Online Retailers
• 6.6. Global Cat Vaccine Market, Sub-Segmentation Of Modified or Attenuated Live, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Feline Viral Rhinotracheitis (FVR) Vaccine
• Feline Calicivirus (FCV) Vaccine
• Feline Panleukopenia (FPV) Vaccine
• 6.7. Global Cat Vaccine Market, Sub-Segmentation Of Inactivated, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inactivated Feline Leukemia Virus (FeLV) Vaccine
• Inactivated Feline Infectious Peritonitis (FIP) Vaccine
• 6.8. Global Cat Vaccine Market, Sub-Segmentation Of Other Vaccine Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Vaccines
• DNA Vaccines
• Subunit Vaccines
• Combination Vaccines

7. Cat Vaccine Market Regional And Country Analysis

• 7.1. Global Cat Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cat Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cat Vaccine Market

• 8.1. Asia-Pacific Cat Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cat Vaccine Market

• 9.1. China Cat Vaccine Market Overview
• 9.2. China Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cat Vaccine Market

• 10.1. India Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cat Vaccine Market

• 11.1. Japan Cat Vaccine Market Overview
• 11.2. Japan Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cat Vaccine Market

• 12.1. Australia Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cat Vaccine Market

• 13.1. Indonesia Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cat Vaccine Market

• 14.1. South Korea Cat Vaccine Market Overview
• 14.2. South Korea Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cat Vaccine Market

• 15.1. Western Europe Cat Vaccine Market Overview
• 15.2. Western Europe Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cat Vaccine Market

• 16.1. UK Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cat Vaccine Market

• 17.1. Germany Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cat Vaccine Market

• 18.1. France Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cat Vaccine Market

• 19.1. Italy Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cat Vaccine Market

• 20.1. Spain Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cat Vaccine Market

• 21.1. Eastern Europe Cat Vaccine Market Overview
• 21.2. Eastern Europe Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cat Vaccine Market

• 22.1. Russia Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cat Vaccine Market

• 23.1. North America Cat Vaccine Market Overview
• 23.2. North America Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cat Vaccine Market

• 24.1. USA Cat Vaccine Market Overview
• 24.2. USA Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cat Vaccine Market

• 25.1. Canada Cat Vaccine Market Overview
• 25.2. Canada Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cat Vaccine Market

• 26.1. South America Cat Vaccine Market Overview
• 26.2. South America Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cat Vaccine Market

• 27.1. Brazil Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cat Vaccine Market

• 28.1. Middle East Cat Vaccine Market Overview
• 28.2. Middle East Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cat Vaccine Market

• 29.1. Africa Cat Vaccine Market Overview
• 29.2. Africa Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cat Vaccine Market Competitive Landscape And Company Profiles

• 30.1. Cat Vaccine Market Competitive Landscape
• 30.2. Cat Vaccine Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. MSD Animal Health Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Cat Vaccine Market Other Major And Innovative Companies

• 31.1. Intas Pharmaceuticals Ltd.
• 31.2. Ceva Sante Animale
• 31.3. Virbac
• 31.4. Neogen Corporation
• 31.5. Indian Immunologicals Ltd.
• 31.6. Jinyu Bio-technology Co. Ltd.
• 31.7. Ourofino Animal Health SA
• 31.8. Biogenesis Bago SA
• 31.9. Valley Vet Supply
• 31.10. HIPRA Corporation
• 31.11. Bioveta AS
• 31.12. China Animal Husbandry Group
• 31.13. Veterinary Pharmaceutical Solutions
• 31.14. Torigen Pharmaceuticals Inc.
• 31.15. KM Vet Pharm Sdn Bhd.

32. Global Cat Vaccine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cat Vaccine Market

34. Recent Developments In The Cat Vaccine Market

35. Cat Vaccine Market High Potential Countries, Segments and Strategies

• 35.1 Cat Vaccine Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cat Vaccine Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cat Vaccine Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250423_r33456_Cat_Vaccine_GMR_2025